Here is the latest shareholding Pattern of DHANVANTRI JEEV. For more details, see the DHANVANTRI JEEV financial fact sheet and DHANVANTRI JEEV share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 19.77 | 19.77 | 19.77 | 19.77 | 19.65 | 19.65 | 19.65 | 19.65 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 19.77 | 19.77 | 19.77 | 19.77 | 19.65 | 19.65 | 19.65 | 19.65 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 14.48 | 14.81 | 15.06 | 15.26 | 15.58 | 15.65 | 15.66 | 15.36 | |
Individuals | % | 51.55 | 41.57 | 41.29 | 41.22 | 41.04 | 40.79 | 40.84 | 41.27 | |
NRIs/OCBs | % | 7.04 | 7.03 | 7.10 | 7.12 | 7.14 | 7.27 | 7.24 | 0.91 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 7.16 | 16.82 | 16.78 | 16.63 | 16.59 | 16.64 | 16.61 | 22.81 | |
Total Non-Institution | % | 80.23 | 80.23 | 80.23 | 80.23 | 80.35 | 80.35 | 80.35 | 80.35 | |
Total Public | % | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Hospital & Healthcare Services Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Indian share markets continued the momentum as the session progressed and ended the higher.